Cargando…

Estimating the proportion of people with chronic hepatitis B virus infection eligible for hepatitis B antiviral treatment worldwide: a systematic review and meta-analysis

BACKGROUND: In 2016, of the estimated 257 million people living with chronic hepatitis B virus (HBV) infection worldwide, only a small proportion was diagnosed and treated. The insufficiency of information on the proportion of people infected with HBV who are eligible for treatment limits the interp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tan, Mingjuan, Bhadoria, Ajeet S, Cui, Fuqiang, Tan, Alex, Van Holten, Judith, Easterbrook, Philippa, Ford, Nathan, Han, Qin, Lu, Ying, Bulterys, Marc, Hutin, Yvan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier B.V 2020
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7801814/ https://www.ncbi.nlm.nih.gov/pubmed/33197397 http://dx.doi.org/10.1016/S2468-1253(20)30307-1

Ejemplares similares

Access to Treatment for Hepatitis B Virus Infection — Worldwide, 2016
por: Hutin, Yvan, et al.
Publicado: (2018)

Preventing hepatitis B virus infection: milestones and targets
por: Hutin, Yvan, et al.
Publicado: (2018)

The global hepatitis delta virus (HDV) epidemic: what gaps to address in order to mount a public health response?
por: Hayashi, Tomoyuki, et al.
Publicado: (2021)

Adherence to Nucleos(t)ide Analogue Therapies for Chronic Hepatitis B Infection: A Systematic Review and Meta‐Analysis
por: Ford, Nathan, et al.
Publicado: (2018)

How far are we from viral hepatitis elimination service coverage targets?
por: Hutin, Yvan J‐F, et al.
Publicado: (2018)

Worldwide prevalence of hepatitis B virus and hepatitis C virus among patients with cirrhosis at country, region, and global levels: a systematic review
por: Alberts, Catharina J, et al.
Publicado: (2022)

Eligibility for hepatitis B antiviral therapy among adults in the general population in Zambia
por: Vinikoor, Michael J., et al.
Publicado: (2020)

Methodological challenges in appraising evidence on diagnostic testing for WHO guidelines on hepatitis B and hepatitis C virus infection
por: Chou, Roger, et al.
Publicado: (2017)

Training the healthcare workforce: the global experience with telementorship for hepatitis B and hepatitis C
por: Corcorran, Maria A., et al.
Publicado: (2023)

Testing for hepatitis in view of treatment: A universal health coverage service that can advance elimination of mother-to-child transmission of hepatitis B virus
por: Hutin, Yvan, et al.
Publicado: (2020)

WHO guidelines on testing for hepatitis B and C – meeting targets for testing
por: Hellard, Margaret E., et al.
Publicado: (2017)

Estimating the price at which hepatitis C treatment with direct-acting antivirals would be cost-saving in Japan
por: Zhuo, Yueran, et al.
Publicado: (2020)

Eligibility for antiviral therapy and treatment uptake in chronic hepatitis B patients referred to a European tertiary care center
por: Jachs, Mathias, et al.
Publicado: (2023)

Development, Production, and Postmarketing Surveillance of Hepatitis A Vaccines in China
por: Cui, Fuqiang, et al.
Publicado: (2014)

Validation of a surveillance-based definition for hepatitis B treatment eligibility.
por: Guerra, Kevin, et al.
Publicado: (2019)

Low eligibility for hepatitis B treatment in the Brazilian public health system
por: Scarponi, Cristiane Faria Oliveira, et al.
Publicado: (2022)

Eliminating mother-to-child transmission of human immunodeficiency virus, syphilis and hepatitis B in sub-Saharan Africa
por: Cohn, Jennifer, et al.
Publicado: (2021)

Cost-Effectiveness of Testing and Treatment for Hepatitis B Virus and Hepatitis C Virus Infections: An Analysis by Scenarios, Regions, and Income
por: Tordrup, David, et al.
Publicado: (2020)

Dynamics of Hepatitis B Virus Pregenomic RNA in Chronic Hepatitis B Patients With Antiviral Therapy Over 9 Years
por: Pan, Jiali, et al.
Publicado: (2022)

Training the healthcare workforce to support task-shifting and viral hepatitis elimination: a global review of English language online trainings and in-person workshops for management of hepatitis B and C infection
por: Corcorran, Maria A., et al.
Publicado: (2023)

National viral hepatitis control program in India: Call for update
por: Pandey, Pragya, et al.
Publicado: (2023)

Diagnosis of viral hepatitis
por: Easterbrook, Philippa J., et al.
Publicado: (2017)

Epidemiological Pattern of Hepatitis B and Hepatitis C as Etiological Agents for Hepatocellular Carcinoma in Iran and Worldwide
por: Zidan, Ahmed, et al.
Publicado: (2012)

Resolution of Multiple Large Spider Angiomas After Liver Transplantation in Severe Alcoholic Hepatitis
por: Jindal, Ankur, et al.
Publicado: (2022)

Prevalence of Hepatitis B and C Among Prison Inmates in India: A Systematic Review and Meta-Analysis
por: Bhadoria, Ajeet S, et al.
Publicado: (2021)

The Impact of Vaccination and Antiviral Therapy on Hepatitis B and Hepatitis D Epidemiology
por: Goyal, Ashish, et al.
Publicado: (2014)

Current Antiviral Therapy for Chronic Hepatitis B
por: Lim, Young-Suk, et al.
Publicado: (2004)

Antiviral treatment in severe acute hepatitis B
por: Streinu-Cercel, Anca, et al.
Publicado: (2014)

Antiviral therapy for chronic hepatitis B in China
por: Zheng, Xin, et al.
Publicado: (2014)

Management of Antiviral Resistance in Chronic Hepatitis B
por: Lim, Young-Suk
Publicado: (2017)

Advances in new antivirals for chronic hepatitis B
por: Tang, Yanhua, et al.
Publicado: (2022)

Circulating and intrahepatic antiviral B cells are defective in hepatitis B
por: Burton, Alice R., et al.
Publicado: (2018)

Time for an active antiviral therapy for hepatitis B: An update on the management of hepatitis B virus infection
por: Chae, Hee Bok, et al.
Publicado: (2007)

A Novel and Simplified Score for Determining Treatment Eligibility for Patients with Chronic Hepatitis B
por: Geeratragool, Tanawat, et al.
Publicado: (2023)

Prevention of Hepatitis C in Women
por: Bell, Beth P., et al.
Publicado: (2004)

Soluble programmed death-1 is predictive of hepatitis B surface antigen loss in chronic hepatitis B patients after antiviral treatment
por: Tan, Ning, et al.
Publicado: (2021)

Effect of Hepatitis B Virus Genotypes on the Efficacy of Adefovir Dipivoxil Antiviral Therapy
por: Wen, Zhili, et al.
Publicado: (2014)

Knowledge, attitude, and practice study on hepatitis B among medical and nursing undergraduate students of an apex healthcare institute at Uttarakhand foothills: A descriptive analysis
por: Chhabra, Disksha, et al.
Publicado: (2019)

Viral Hepatitis Strategic Information to Achieve Elimination by 2030: Key Elements for HIV Program Managers
por: Hutin, Yvan, et al.
Publicado: (2017)

Assessment and validation of the TREAT-B score to assess the treatment eligibility of patients with chronic hepatitis B virus infection
por: Thanapirom, Kessarin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_d6udq199gqiism71aiiuq5bd8c